For first-time users, start at 0.6mg per dose to monitor for side effects, and if appetite suppression is insufficient, gradually increase the dose each week by 0.6mg up to a maximum of 3.0mg
GLP-1 RA-MWL leads to AT depletion, with associated skin laxity, volume loss, and accelerated aging, particularly in periorbital and midfacial regions
Unless, of course, there is some kind of additional pro-sarcopenia mechanism at play
Innate Fe-Redox regulators such as lactoferrin (LF), heme oxygenase (HO)-1, erythropoietin (EPO), and hepcidin (HEP) serve as front-line innate barriers against free radical (ROS/RNS) damage and hyper-immune responses during COVID-19 and PASC 27
Clinicians should measure albumin before initiating therapy and recheck it at each monitoring visit